v3.23.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Current assets:      
Cash and cash equivalents $ 1,464,381 $ 3,147,702 $ 12,264,736
Unbilled receivable 107,738 276,821 441,721
Right-of-use asset 2,717 27,165 24,721
Prepaid expenses and other current assets 1,182,967 1,847,481 2,931,415
Total current assets 2,757,803 5,299,169 15,662,593
Property and equipment, net  
Other assets 460,883 585,883 754,756
Total assets 3,218,686 5,885,052 16,417,349
Current liabilities:      
Accounts payable 916,416 2,943,791 301,104
Accrued expenses and other liabilities 760,458 2,226,494 3,407,533
Lease liability 2,732 27,315 24,874
Notes payable and accrued interest 350,932 4,266,610 12,748,155
Total current liabilities 2,030,538 9,464,210 16,481,666
Long-term liabilities:      
Notes payable, net of current portion 140,148 4,440,951
Liability classified warrants 30,473 310,346  
Other long-term liabilities   310,346 3,652,790
Total long-term liabilities 30,473 450,494 8,093,741
Total liabilities 2,061,011 9,914,704 24,575,407
Commitments and contingencies (Note 6)
Stockholders’ equity (deficit)      
Preferred stock, $0.0001 par value, 1,500,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022
Common stock, $0.0001 par value, 250,000,000 shares authorized at September 30, 2023 and December 31, 2022; 2,864,085 and 534,571 shares issued at September 30, 2023 and December 31, 2022, respectively; 2,864,004 and 534,490 shares outstanding at September 30, 2023 and December 31, 2022, respectively 287 53 10
Additional paid-in capital 119,537,611 107,216,566 77,967,314
Accumulated deficit (118,052,779) (110,931,063) (85,845,567)
Total Ensysce Biosciences, Inc. stockholders’ equity (deficit) 1,485,119 (3,714,444) (7,878,243)
Noncontrolling interests in stockholders’ equity (deficit) (327,444) (315,208) (279,815)
Total stockholders’ equity (deficit) 1,157,675 (4,029,652) (8,158,058)
Total liabilities and stockholders’ equity (deficit) $ 3,218,686 $ 5,885,052 $ 16,417,349